Related Experiment Video
Updated: Aug 13, 2026
Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
Treatment of culture-negative skull base osteomyelitis
Hamid R Djalilian1, Bahman Shamloo, Kunal H Thakkar
1Division of Neurotology and Skull Base Surgery, Department of Otolaryngology-Head and Neck Surgery, Charles R. Drew University of Medicine and Science, Los Angeles County Hospital, Los Angeles, California, USA. skullbasesurgery@yahoo.com
Objective:
To evaluate the efficacy of a therapeutic regimen in the treatment of patients with culture-negative skull base osteomyelitis.
Study Design:
Retrospective case review.
Setting:
Tertiary referral hospital.
Patients:
Eight patients with diabetes mellitus presented with otalgia and were found to have positive technetium and gallium scans of the temporal bone. These patients, however, all had negative cultures of their external auditory canals. All patients had been treated with ototopic drops and two patients had undergone a 2-week course of oral quinolones.
Interventions:
All patients were treated with a 6-week course of intravenous ceftazidime or aztreonam for penicillin-allergic patients, oral ciprofloxacin at a higher dose than normal, and topical aminoglycoside steroid drops.
Main Outcome Measures:
Resolution of the temporal bone gallium scan abnormality, recurrence rate, and time to discharge from the hospital.
Results:
The patients were discharged from the hospital within 4 days from admission. All patients showed resolution of the temporal bone abnormality on the gallium scan at the 6-week time point. The median follow-up period was 6 months, and none of the patients had a recurrence of the infection.
Conclusion:
The above-described treatment regimen will result in a high cure rate and a short hospitalization period.
Related Concept Videos
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:27Cryptococcal Meningitis